Susan Rountree

8.0k total citations
15 papers, 643 citations indexed

About

Susan Rountree is a scholar working on Psychiatry and Mental health, Physiology and Pharmacology. According to data from OpenAlex, Susan Rountree has authored 15 papers receiving a total of 643 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Psychiatry and Mental health, 5 papers in Physiology and 3 papers in Pharmacology. Recurrent topics in Susan Rountree's work include Dementia and Cognitive Impairment Research (12 papers), Alzheimer's disease research and treatments (3 papers) and Cholinesterase and Neurodegenerative Diseases (3 papers). Susan Rountree is often cited by papers focused on Dementia and Cognitive Impairment Research (12 papers), Alzheimer's disease research and treatments (3 papers) and Cholinesterase and Neurodegenerative Diseases (3 papers). Susan Rountree collaborates with scholars based in United States, South Korea and Canada. Susan Rountree's co-authors include Rachelle S. Doody, Eveleen Darby, Valory Pavlik, Wenyaw Chan, Paul J. Massman, Hong Li, Samina Siddiqui, Jin Yan, Alireza Atri and Oscar L. López and has published in prestigious journals such as Journal of the Neurological Sciences, Journal of Alzheimer s Disease and Journal of Psychiatric Research.

In The Last Decade

Susan Rountree

14 papers receiving 618 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Susan Rountree United States 10 353 215 120 95 95 15 643
Yvonne Wirth Germany 8 321 0.9× 234 1.1× 278 2.3× 75 0.8× 132 1.4× 12 716
Christopher Marano United States 9 502 1.4× 207 1.0× 140 1.2× 71 0.7× 83 0.9× 13 748
Eveleen Darby United States 7 250 0.7× 232 1.1× 84 0.7× 50 0.5× 75 0.8× 11 525
Julien Delrieu France 14 298 0.8× 246 1.1× 58 0.5× 81 0.9× 45 0.5× 45 533
Yukimichi Imai Japan 7 308 0.9× 131 0.6× 149 1.2× 57 0.6× 80 0.8× 10 559
Lara Schneider United States 5 481 1.4× 241 1.1× 275 2.3× 77 0.8× 107 1.1× 6 775
SJ Edwards United Kingdom 4 373 1.1× 184 0.9× 295 2.5× 62 0.7× 69 0.7× 6 751
Timothy Hsu United States 11 241 0.7× 201 0.9× 171 1.4× 107 1.1× 87 0.9× 24 755
Judith Neugroschl United States 14 215 0.6× 237 1.1× 81 0.7× 65 0.7× 64 0.7× 44 725
Jeanette Günther United States 7 361 1.0× 229 1.1× 46 0.4× 124 1.3× 85 0.9× 14 604

Countries citing papers authored by Susan Rountree

Since Specialization
Citations

This map shows the geographic impact of Susan Rountree's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susan Rountree with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susan Rountree more than expected).

Fields of papers citing papers by Susan Rountree

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Susan Rountree. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susan Rountree. The network helps show where Susan Rountree may publish in the future.

Co-authorship network of co-authors of Susan Rountree

This figure shows the co-authorship network connecting the top 25 collaborators of Susan Rountree. A scholar is included among the top collaborators of Susan Rountree based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Susan Rountree. Susan Rountree is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Gauthier, Serge, et al.. (2015). Effects of the Acetylcholine Release Agent ST101 with Donepezil in Alzheimer’s Disease: A Randomized Phase 2 Study. Journal of Alzheimer s Disease. 48(2). 473–481. 17 indexed citations
2.
Rountree, Susan, Wenyaw Chan, Valory Pavlik, Eveleen Darby, & Rachelle S. Doody. (2012). Factors that influence survival in a probable Alzheimer disease cohort. Alzheimer s Research & Therapy. 4(3). 16–16. 49 indexed citations
3.
Atri, Alireza, Susan Rountree, Oscar L. López, & Rachelle S. Doody. (2012). Validity, Significance, Strengths, Limitations, and Evidentiary Value of Real-World Clinical Data for Combination Therapy in Alzheimer’s Disease: Comparison of Efficacy and Effectiveness Studies. Neurodegenerative Diseases. 10(1-4). 170–174. 20 indexed citations
4.
Rountree, Susan, Alireza Atri, Oscar L. López, & Rachelle S. Doody. (2012). Effectiveness of antidementia drugs in delaying Alzheimer's disease progression. Alzheimer s & Dementia. 9(3). 338–345. 72 indexed citations
5.
Rountree, Susan, et al.. (2012). P2‐321: Factors that influence nursing home placement in an Alzheimer's disease cohort. Alzheimer s & Dementia. 8(4S_Part_10). 1 indexed citations
6.
Rountree, Susan, Wenyaw Chan, Valory Pavlik, Eveleen Darby, & Rachelle S. Doody. (2011). O3‐07‐04: Factors that influence survival in Alzheimer's patients. Alzheimer s & Dementia. 7(4S_Part_15). 3 indexed citations
7.
Doody, Rachelle S., Valory Pavlik, Paul J. Massman, et al.. (2010). Predicting progression of Alzheimer's disease. Alzheimer s Research & Therapy. 2(1). 2–2. 97 indexed citations
8.
Pavlik, Valory, Rachelle S. Doody, Susan Rountree, & Eveleen Darby. (2009). Vitamin E Use Is Associated with Improved Survival in an Alzheimer’s Disease Cohort. Dementia and Geriatric Cognitive Disorders. 28(6). 536–540. 33 indexed citations
9.
Rountree, Susan, Wenyaw Chan, Valory Pavlik, et al.. (2009). Persistent treatment with cholinesterase inhibitors and/or memantine slows clinical progression of Alzheimer disease. Alzheimer s Research & Therapy. 1(2). 7–7. 142 indexed citations
10.
Yan, Jin, Susan Rountree, Paul J. Massman, Rachelle S. Doody, & Hong Li. (2008). Alzheimer’s disease and mild cognitive impairment deteriorate fine movement control. Journal of Psychiatric Research. 42(14). 1203–1212. 120 indexed citations
11.
Rountree, Susan, et al.. (2008). Weight change in Parkinson and Alzheimer patients taking atypical antipsychotic drugs. Journal of the Neurological Sciences. 272(1-2). 77–82. 5 indexed citations
12.
Rountree, Susan, Valory Pavlik, Wenyaw Chan, & Rachelle S. Doody. (2008). P4‐102: Persistent antidementia drug treatment and survival in an Alzheimer's disease (AD) cohort. Alzheimer s & Dementia. 4(4S_Part_21). 1 indexed citations
13.
Park, Kyung Won, Valory Pavlik, Susan Rountree, Eveleen Darby, & Rachelle S. Doody. (2007). Is Functional Decline Necessary for a Diagnosis of Alzheimer’s Disease?. Dementia and Geriatric Cognitive Disorders. 24(5). 375–379. 18 indexed citations
14.
Rountree, Susan, Stephen C. Waring, Wai Chi Chan, et al.. (2007). Importance of Subtle Amnestic and Nonamnestic Deficits in Mild Cognitive Impairment: Prognosis and Conversion to Dementia. Dementia and Geriatric Cognitive Disorders. 24(6). 476–482. 64 indexed citations
15.
Park, Kyung Won, Valory Pavlik, Susan Rountree, Eveleen Darby, & Rachelle S. Doody. (2006). P2–103: Is functional decline necessary for a diagnosis of Alzheimer's disease?. Alzheimer s & Dementia. 2(3S_Part_9). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026